Bridging epigenetics and metabolism

References

• Knudson AG Jr.. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971; 68:820 - 3; http://dx.doi.org/10.1073/pnas.68.4.820; PMID: 5279523
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Kinzler KW. The multistep nature of cancer. Trends Genet 1993; 9:138 - 41; http://dx.doi.org/10.1016/0168-9525(93)90209-Z; PMID: 8516849
   PubMed Web of Science ®Google Scholar
• Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med 2004; 10:789 - 99; http://dx.doi.org/10.1038/nm1087; PMID: 15286780
   PubMed Web of Science ®Google Scholar
• Esteller M. Epigenetics in cancer. N Engl J Med 2008; 358:1148 - 59; http://dx.doi.org/10.1056/NEJMra072067; PMID: 18337604
   PubMed Web of Science ®Google Scholar
• Baylin SB, Jones PA. A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer 2011; 11:726 - 34; http://dx.doi.org/10.1038/nrc3130; PMID: 21941284
   PubMed Web of Science ®Google Scholar
• Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell 2012; 150:12 - 27; http://dx.doi.org/10.1016/j.cell.2012.06.013; PMID: 22770212
   PubMed Web of Science ®Google Scholar
• Robertson KD. DNA methylation and human disease. Nat Rev Genet 2005; 6:597 - 610; http://dx.doi.org/10.1038/nrg1655; PMID: 16136652
   PubMed Web of Science ®Google Scholar
• Heintzman ND, Hon GC, Hawkins RD, Kheradpour P, Stark A, Harp LF, et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 2009; 459:108 - 12; http://dx.doi.org/10.1038/nature07829; PMID: 19295514
   PubMed Web of Science ®Google Scholar
• Yun J, Johnson JL, Hanigan CL, Locasale JW. Interactions between epigenetics and metabolism in cancers. Front Oncol 2012; 2:163; http://dx.doi.org/10.3389/fonc.2012.00163; PMID: 23162793
   PubMedGoogle Scholar
• Lu C, Thompson CB. Metabolic regulation of epigenetics. Cell Metab 2012; 16:9 - 17; http://dx.doi.org/10.1016/j.cmet.2012.06.001; PMID: 22768835
   PubMed Web of Science ®Google Scholar
• Cai L, Sutter BM, Li B, Tu BP. Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes. Mol Cell 2011; 42:426 - 37; http://dx.doi.org/10.1016/j.molcel.2011.05.004; PMID: 21596309
   PubMed Web of Science ®Google Scholar
• Lin SJ, Defossez PA, Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 2000; 289:2126 - 8; http://dx.doi.org/10.1126/science.289.5487.2126; PMID: 11000115
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008; 7:11 - 20; http://dx.doi.org/10.1016/j.cmet.2007.10.002; PMID: 18177721
   PubMed Web of Science ®Google Scholar
• Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer’s Achilles’ heel. Cancer Cell 2008; 13:472 - 82; http://dx.doi.org/10.1016/j.ccr.2008.05.005; PMID: 18538731
   PubMed Web of Science ®Google Scholar
• Warburg O. On the origin of cancer cells. Science 1956; 123:309 - 14; http://dx.doi.org/10.1126/science.123.3191.309; PMID: 13298683
   PubMed Web of Science ®Google Scholar
• Cardaci S, Ciriolo MR. TCA Cycle Defects and Cancer: When Metabolism Tunes Redox State. Int J Cell Biol 2012; 2012:161837; http://dx.doi.org/10.1155/2012/161837; PMID: 22888353
   PubMedGoogle Scholar
• Vousden KH, Ryan KM. p53 and metabolism. Nat Rev Cancer 2009; 9:691 - 700; http://dx.doi.org/10.1038/nrc2715; PMID: 19759539
   PubMed Web of Science ®Google Scholar
• Dang CV. MYC, microRNAs and glutamine addiction in cancers. Cell Cycle 2009; 8:3243 - 5; http://dx.doi.org/10.4161/cc.8.20.9522; PMID: 19806017
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324:1029 - 33; http://dx.doi.org/10.1126/science.1160809; PMID: 19460998
   PubMed Web of Science ®Google Scholar
• Locasale JW, Cantley LC. Metabolic flux and the regulation of mammalian cell growth. Cell Metab 2011; 14:443 - 51; http://dx.doi.org/10.1016/j.cmet.2011.07.014; PMID: 21982705
   PubMed Web of Science ®Google Scholar
• Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 2004; 50:1511 - 25; http://dx.doi.org/10.1373/clinchem.2004.032482; PMID: 15265818
   PubMed Web of Science ®Google Scholar
• Gillies RJ, Robey I, Gatenby RA. Causes and consequences of increased glucose metabolism of cancers. J Nucl Med 2008; 49:Suppl 2 24S - 42S; http://dx.doi.org/10.2967/jnumed.107.047258; PMID: 18523064
   PubMed Web of Science ®Google Scholar
• Phang JM, Liu W, Hancock C, Christian KJ. The proline regulatory axis and cancer. Front Oncol 2012; 2:60; http://dx.doi.org/10.3389/fonc.2012.00060; PMID: 22737668
   PubMedGoogle Scholar
• Payne SH, Loomis WF. Retention and loss of amino acid biosynthetic pathways based on analysis of whole-genome sequences. Eukaryot Cell 2006; 5:272 - 6; http://dx.doi.org/10.1128/EC.5.2.272-276.2006; PMID: 16467468
   PubMed Web of Science ®Google Scholar
• Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 2011; 476:346 - 50; http://dx.doi.org/10.1038/nature10350; PMID: 21760589
   PubMed Web of Science ®Google Scholar
• Le A, Lane AN, Hamaker M, Bose S, Gouw A, Barbi J, et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab 2012; 15:110 - 21; http://dx.doi.org/10.1016/j.cmet.2011.12.009; PMID: 22225880
   PubMed Web of Science ®Google Scholar
• Darmaun D, Matthews DE, Bier DM. Physiological hypercortisolemia increases proteolysis, glutamine, and alanine production. Am J Physiol 1988; 255:E366 - 73; PMID: 3048115
   PubMed Web of Science ®Google Scholar
• Chiang PK, Gordon RK, Tal J, Zeng GC, Doctor BP, Pardhasaradhi K, et al. S-Adenosylmethionine and methylation. FASEB J 1996; 10:471 - 80; PMID: 8647346
   PubMed Web of Science ®Google Scholar
• Barron JT, Gu L, Parrillo JE. Malate-aspartate shuttle, cytoplasmic NADH redox potential, and energetics in vascular smooth muscle. J Mol Cell Cardiol 1998; 30:1571 - 9; http://dx.doi.org/10.1006/jmcc.1998.0722; PMID: 9737943
   PubMed Web of Science ®Google Scholar
• Takamura Y, Nomura G. Changes in the intracellular concentration of acetyl-CoA and malonyl-CoA in relation to the carbon and energy metabolism of Escherichia coli K12. J Gen Microbiol 1988; 134:2249 - 53; PMID: 3075658
   PubMedGoogle Scholar
• Vander Heiden MG, Lunt SY, Dayton TL, Fiske BP, Israelsen WJ, Mattaini KR, et al. Metabolic Pathway Alterations that Support Cell Proliferation. Cold Spring Harb Symp Quant Biol 2012.
   Google Scholar
• Phang JM, Donald SP, Pandhare J, Liu Y. The metabolism of proline, a stress substrate, modulates carcinogenic pathways. Amino Acids 2008; 35:681 - 90; http://dx.doi.org/10.1007/s00726-008-0063-4; PMID: 18401543
   PubMed Web of Science ®Google Scholar
• Phang JM, Liu W. Proline metabolism and cancer. Front Biosci 2012; 17:1835 - 45; http://dx.doi.org/10.2741/4022; PMID: 22201839
   PubMed Web of Science ®Google Scholar
• Adams E, Frank L. Metabolism of proline and the hydroxyprolines. Annu Rev Biochem 1980; 49:1005 - 61; http://dx.doi.org/10.1146/annurev.bi.49.070180.005041; PMID: 6250440
   PubMed Web of Science ®Google Scholar
• Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature 1997; 389:300 - 5; http://dx.doi.org/10.1038/38525; PMID: 9305847
   PubMed Web of Science ®Google Scholar
• Donald SP, Sun XY, Hu CA, Yu J, Mei JM, Valle D, et al. Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species. Cancer Res 2001; 61:1810 - 5; PMID: 11280728
   PubMed Web of Science ®Google Scholar
• Maxwell SA, Rivera A. Proline oxidase induces apoptosis in tumor cells, and its expression is frequently absent or reduced in renal carcinomas. J Biol Chem 2003; 278:9784 - 9; http://dx.doi.org/10.1074/jbc.M210012200; PMID: 12514185
   PubMed Web of Science ®Google Scholar
• Pandhare J, Cooper SK, Phang JM. Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms. J Biol Chem 2006; 281:2044 - 52; http://dx.doi.org/10.1074/jbc.M507867200; PMID: 16303758
   PubMed Web of Science ®Google Scholar
• Liu Y, Borchert GL, Surazynski A, Hu CA, Phang JM. Proline oxidase activates both intrinsic and extrinsic pathways for apoptosis: the role of ROS/superoxides, NFAT and MEK/ERK signaling. Oncogene 2006; 25:5640 - 7; http://dx.doi.org/10.1038/sj.onc.1209564; PMID: 16619034
   PubMed Web of Science ®Google Scholar
• Liu Y, Borchert GL, Donald SP, Surazynski A, Hu CA, Weydert CJ, et al. MnSOD inhibits proline oxidase-induced apoptosis in colorectal cancer cells. Carcinogenesis 2005; 26:1335 - 42; http://dx.doi.org/10.1093/carcin/bgi083; PMID: 15817612
   PubMed Web of Science ®Google Scholar
• Liu Y, Borchert GL, Donald SP, Diwan BA, Anver M, Phang JM. Proline oxidase functions as a mitochondrial tumor suppressor in human cancers. Cancer Res 2009; 69:6414 - 22; http://dx.doi.org/10.1158/0008-5472.CAN-09-1223; PMID: 19654292
   PubMed Web of Science ®Google Scholar
• Hu CA, Donald SP, Yu J, Lin WW, Liu Z, Steel G, et al. Overexpression of proline oxidase induces proline-dependent and mitochondria-mediated apoptosis. Mol Cell Biochem 2007; 295:85 - 92; http://dx.doi.org/10.1007/s11010-006-9276-6; PMID: 16874462
   PubMed Web of Science ®Google Scholar
• Liu W, Glunde K, Bhujwalla ZM, Raman V, Sharma A, Phang JM. Proline oxidase promotes tumor cell survival in hypoxic tumor microenvironments. Cancer Res 2012; 72:3677 - 86; http://dx.doi.org/10.1158/0008-5472.CAN-12-0080; PMID: 22609800
   PubMed Web of Science ®Google Scholar
• Pandhare J, Donald SP, Cooper SK, Phang JM. Regulation and function of proline oxidase under nutrient stress. J Cell Biochem 2009; 107:759 - 68; http://dx.doi.org/10.1002/jcb.22174; PMID: 19415679
   PubMed Web of Science ®Google Scholar
• Liu W, Zabirnyk O, Wang H, Shiao YH, Nickerson ML, Khalil S, et al. miR-23b targets proline oxidase, a novel tumor suppressor protein in renal cancer. Oncogene 2010; 29:4914 - 24; http://dx.doi.org/10.1038/onc.2010.237; PMID: 20562915
   PubMed Web of Science ®Google Scholar
• Liu W, Le A, Hancock C, Lane AN, Dang CV, Fan TW, et al. Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC. Proc Natl Acad Sci U S A 2012; 109:8983 - 8; http://dx.doi.org/10.1073/pnas.1203244109; PMID: 22615405
   PubMed Web of Science ®Google Scholar
• Wanduragala S, Sanyal N, Liang X, Becker DF. Purification and characterization of Put1p from Saccharomyces cerevisiae. Arch Biochem Biophys 2010; 498:136 - 42; http://dx.doi.org/10.1016/j.abb.2010.04.020; PMID: 20450881
   PubMed Web of Science ®Google Scholar
• Chandel NS. Mitochondrial complex III: an essential component of universal oxygen sensing machinery?. Respir Physiol Neurobiol 2010; 174:175 - 81; http://dx.doi.org/10.1016/j.resp.2010.08.004; PMID: 20708106
   PubMed Web of Science ®Google Scholar
• Adams E. Metabolism of proline and of hydroxyproline. Int Rev Connect Tissue Res 1970; 5:1 - 91; PMID: 5500436
   PubMedGoogle Scholar
• Phang JM. The regulatory functions of proline and pyrroline-5-carboxylic acid. Curr Top Cell Regul 1985; 25:91 - 132; PMID: 2410198
   PubMedGoogle Scholar
• Willis A, Bender HU, Steel G, Valle D. PRODH variants and risk for schizophrenia. Amino Acids 2008; 35:673 - 9; http://dx.doi.org/10.1007/s00726-008-0111-0; PMID: 18528746
   PubMed Web of Science ®Google Scholar
• Cooper SK, Pandhare J, Donald SP, Phang JM. A novel function for hydroxyproline oxidase in apoptosis through generation of reactive oxygen species. J Biol Chem 2008; 283:10485 - 92; http://dx.doi.org/10.1074/jbc.M702181200; PMID: 18287100
   PubMed Web of Science ®Google Scholar
• Wang R, Dillon CP, Shi LZ, Milasta S, Carter R, Finkelstein D, et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 2011; 35:871 - 82; http://dx.doi.org/10.1016/j.immuni.2011.09.021; PMID: 22195744
   PubMed Web of Science ®Google Scholar
• Stoner GD, Merchant DJ. Amino acid utilization by L-M strain mouse cells in a chemically defined medium. In Vitro 1972; 7:330 - 43; PMID: 5064338
   PubMedGoogle Scholar
• Windmueller HG, Spaeth AE. Uptake and metabolism of plasma glutamine by the small intestine. J Biol Chem 1974; 249:5070 - 9; PMID: 4605420
   PubMed Web of Science ®Google Scholar
• Reversade B, Escande-Beillard N, Dimopoulou A, Fischer B, Chng SC, Li Y, et al. Mutations in PYCR1 cause cutis laxa with progeroid features. Nat Genet 2009; 41:1016 - 21; http://dx.doi.org/10.1038/ng.413; PMID: 19648921
   PubMed Web of Science ®Google Scholar
• Meng Z, Lou Z, Liu Z, Li M, Zhao X, Bartlam M, et al. Crystal structure of human pyrroline-5-carboxylate reductase. J Mol Biol 2006; 359:1364 - 77; http://dx.doi.org/10.1016/j.jmb.2006.04.053; PMID: 16730026
   PubMed Web of Science ®Google Scholar
• De Ingeniis J, Ratnikov B, Richardson AD, Scott DA, Aza-Blanc P, De SK, et al. Functional specialization in proline biosynthesis of melanoma. PLoS One 2012; 7:e45190; http://dx.doi.org/10.1371/journal.pone.0045190; PMID: 23024808
   PubMedGoogle Scholar
• Baumgartner MR, Hu CA, Almashanu S, Steel G, Obie C, Aral B, et al. Hyperammonemia with reduced ornithine, citrulline, arginine and proline: a new inborn error caused by a mutation in the gene encoding delta(1)-pyrroline-5-carboxylate synthase. Hum Mol Genet 2000; 9:2853 - 8; http://dx.doi.org/10.1093/hmg/9.19.2853; PMID: 11092761
   PubMed Web of Science ®Google Scholar
• Provenzano PP, Inman DR, Eliceiri KW, Keely PJ. Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage. Oncogene 2009; 28:4326 - 43; http://dx.doi.org/10.1038/onc.2009.299; PMID: 19826415
   PubMed Web of Science ®Google Scholar
• Fujimoto WY, Subak-Sharpe JH, Seegmiller JE. Hypoxanthine-guanine phosphoribosyltransferase deficiency: chemical agents selective for mutant or normal cultured fibroblasts in mixed and heterozygote cultures. Proc Natl Acad Sci U S A 1971; 68:1516 - 9; http://dx.doi.org/10.1073/pnas.68.7.1516; PMID: 5283941
   PubMed Web of Science ®Google Scholar
• Fiaschi T, Marini A, Giannoni E, Taddei ML, Gandellini P, De Donatis A, et al. Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. Cancer Res 2012; 72:5130 - 40; http://dx.doi.org/10.1158/0008-5472.CAN-12-1949; PMID: 22850421
   PubMed Web of Science ®Google Scholar
• Phang JM, Yeh GC, Hagedorn CH. The intercellular proline cycle. Life Sci 1981; 28:53 - 8; http://dx.doi.org/10.1016/0024-3205(81)90365-9; PMID: 6894321
   PubMed Web of Science ®Google Scholar
• Hagedorn CH, Yeh GC, Phang JM. Transfer of 1-pyrroline-5-carboxylate as oxidizing potential from hepatocytes to erythrocytes. Biochem J 1982; 202:31 - 9; PMID: 7082315
   PubMed Web of Science ®Google Scholar
• Phang JM, Downing SJ, Yeh GC, Smith RJ, Williams JA, Hagedorn CH. Stimulation of the hexosemonophosphate-pentose pathway by pyrroline-5-carboxylate in cultured cells. J Cell Physiol 1982; 110:255 - 61; http://dx.doi.org/10.1002/jcp.1041100306; PMID: 6896335
   PubMed Web of Science ®Google Scholar
• Cyr AR, Domann FE. The redox basis of epigenetic modifications: from mechanisms to functional consequences. Antioxid Redox Signal 2011; 15:551 - 89; http://dx.doi.org/10.1089/ars.2010.3492; PMID: 20919933
   PubMed Web of Science ®Google Scholar
• Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, et al. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology 2008; 135:2128 - 40, 2140, e1-8; http://dx.doi.org/10.1053/j.gastro.2008.07.027; PMID: 18801366
   PubMed Web of Science ®Google Scholar
• Washington JM, Rathjen J, Felquer F, Lonic A, Bettess MD, Hamra N, et al. L-Proline induces differentiation of ES cells: a novel role for an amino acid in the regulation of pluripotent cells in culture. Am J Physiol Cell Physiol 2010; 298:C982 - 92; http://dx.doi.org/10.1152/ajpcell.00498.2009; PMID: 20164384
   PubMedGoogle Scholar
• Casalino L, Comes S, Lambazzi G, De Stefano B, Filosa S, De Falco S, et al. Control of embryonic stem cell metastability by L-proline catabolism. J Mol Cell Biol 2011; 3:108 - 22; http://dx.doi.org/10.1093/jmcb/mjr001; PMID: 21307025
   PubMed Web of Science ®Google Scholar
• Zarse K, Schmeisser S, Groth M, Priebe S, Beuster G, Kuhlow D, et al. Impaired insulin/IGF1 signaling extends life span by promoting mitochondrial L-proline catabolism to induce a transient ROS signal. Cell Metab 2012; 15:451 - 65; http://dx.doi.org/10.1016/j.cmet.2012.02.013; PMID: 22482728
   PubMed Web of Science ®Google Scholar
• Schroeder EA, Shadel GS. Alternative mitochondrial fuel extends life span. Cell Metab 2012; 15:417 - 8; http://dx.doi.org/10.1016/j.cmet.2012.03.011; PMID: 22482723
   PubMed Web of Science ®Google Scholar